Pharma Journalist -

Novavax, Inc. announced that the Singapore Health Sciences Authority (HSA) has issued interim authorization for Nuvaxovid COVID-19 Vaccine (recombinant, adjuvanted) for active…
Read More...

Collegium Pharmaceutical, Inc. and BioDelivery Sciences International, Inc. announced a definitive agreement pursuant to which Collegium will acquire BDSI for $5.60 per share in cash.…
Read More...

Axcella Therapeutics, a clinical-stage biotechnology company pioneering a new approach to treat complex diseases using multi-targeted endogenous metabolic modulator (EMM) compositions,…
Read More...

 Pfizer Inc. and BioNTech SE announced plans to extend their rolling submission to the U.S. Food and Drug Administration (FDA) seeking to amend the Emergency Use Authorization of the…
Read More...

RNA therapeutics is at a critical stage following the success of the COVID-19 mRNA vaccines. Beyond mRNA vaccines, innovative developments are being made using siRNA, microRNA, tRNA and…
Read More...

Quoin Pharmaceuticals Ltd. announced that its wholly-owned subsidiary, Quoin Pharmaceuticals, Inc., has entered into an exclusive Distribution Agreement with ER-Kim, a partner for…
Read More...

Bayer today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for its investigational drug asundexian (BAY2433334) as a potential treatment…
Read More...

Novartis India Limited (NIL) announced an exclusive sales and distribution agreement with Dr. Reddy’s Laboratories (Dr. Reddy’s) for a few of its Established Medicines which includes…
Read More...

Asymchem Laboratories (Tianjin) Co., Ltd. announced its agreement to acquire Snapdragon Chemistry, Inc., a US-based chemical technology company providing industry-leading expertise in…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced a new supply agreement with the government of Colombia for 10.8 million doses…
Read More...